---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-022755"
form_type: "8-K"
ticker: "VRCA"
cik: "0001660334"
company_name: "Verrica Pharmaceuticals Inc."
filed_at: "2023-02-02T23:59:59+00:00"
generated_at: "2026-06-20T02:27:49.935064+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Verrica posts updated corporate presentation; no material specifics disclosed

## Summary
- Company furnished an updated corporate presentation under Regulation FD on Feb 2, 2023.
- Presentation posted on Verrica's website; no financial or operational guidance provided in filing.
- No material new facts available from the exhibit summary provided.

## SEC filing metadata
- accession: 0001193125-23-022755
- form_type: 8-K
- ticker: VRCA
- cik: 0001660334
- company_name: Verrica Pharmaceuticals Inc.
- filed_at: 2023-02-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1660334/000119312523022755/0001193125-23-022755-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1660334/000119312523022755/d456300d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-022755
- JSON: https://secwatch.observer/filing/0001193125-23-022755.json
- Plain text: https://secwatch.observer/filing/0001193125-23-022755.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.